![Sigrid Booms](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Sigrid Booms
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Hermo Pharma Oy
![]() Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd.
9
| Extinct | Pharmaceuticals: Major | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sigrid Booms
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Chairman Director/Board Member Founder Chairman Chief Executive Officer Founder | |
University of Helsinki | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Laurantis Pharma Oy
![]() Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
Suomen Bioteollisuus ry | Chairman Chairman | ||
Orion Pharma Oy
![]() Orion Pharma Oy Pharmaceuticals: MajorHealth Technology Orion Pharma Oy provides contract manufacturing services to the pharmaceutical sector. Its services include sterile, solid forms, liquid forms, semi-solid forms, hormone, and anti-cancer production, primary as well as secondary packaging, and testing. The company is headquartered in Espoo, Finland. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Miscellaneous Commercial Services | Director/Board Member Founder | |
MediSapiens Oy
![]() MediSapiens Oy Packaged SoftwareTechnology Services MediSapiens Oy provides solutions for bioinformatics analysis. It offers software and products for biological research. The firm creates customized bioinformatics software solutions to organizations; ranging from data management system, to full sample and data processing system, to an animal deoxyribonucleic acid testing service. Its products include Biond Explorer; Research Integrator; IST Online; Target Scout; and Fusion Scout. The company was founded by Sami Kalevi Kilpinen, Olli-Pekka Kallioniemi, and Tommi Pisto in 2009 and is headquartered in Helsinki, Finland. | Packaged Software | Director/Board Member Director/Board Member | |
Targovax Oy
![]() Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Biotie Therapies International Oy | Director/Board Member | ||
Stanford University | College/University | Corporate Officer/Principal | |
University of Turku | College/University | Doctorate Degree | |
AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Kemianteollisuus ry | Director/Board Member | ||
Domainex Ltd.
![]() Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chief Executive Officer | |
University of Tartu | College/University | Doctorate Degree | |
Immunophotonics, Inc.
![]() Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI. | Pharmaceuticals: Major | Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
![]() European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Hever Group
![]() Hever Group Personnel ServicesCommercial Services Part of Amrop International, Hever Group is a British company that provides headhunting services. The company is based in London, UK. Hever Group was acquired by Amrop International on June 15, 2000. | Personnel Services | Chairman | |
European Molecular Biology Organization | Director/Board Member | ||
Veraventure Oy
![]() Veraventure Oy Investment ManagersFinance Veraventure Oy is a venture capital investment firm based in Kuopio, Finland. Established in 2003, they are a wholly-owned subsidiary of Finnvera Oy. Veraventure is responsible for the management and development of the parent firm's investments linked to regional funds. Finnvera is a specialized financing firm, owned and operated by the Finnish Government and supervised by the Ministry of Trade and Industry. Veraventure specializes in complementing regional markets in equity financing. They have a particular focus on early-stage financing as well as providing capital related to generational changes and for small and mid-size firms. They are the investment manager of the Seed Fund Vera. The firm also has offices in Oulu and Helsinki, Finland. | Investment Managers | Private Equity Investor | |
Meles Consulting Oy
![]() Meles Consulting Oy Miscellaneous Commercial ServicesCommercial Services Meles Consulting Oy provides management consulting services. The private company is based in Espoo, Finland. The CEO of the Finnish company is Pekka Ilmari Simula. | Miscellaneous Commercial Services | Chief Executive Officer | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
Innovestor Ventures Oy
![]() Innovestor Ventures Oy Investment ManagersFinance Innovestor Ventures Oy is a venture capital firm, a subsidiary of Innovestor Oy founded in 2014. The firm is headquartered in Helsinki, Finland. | Investment Managers | Private Equity Investor | |
HVR Cardio Oy
![]() HVR Cardio Oy Medical SpecialtiesHealth Technology HVR Cardio Oy is a Finnish cardiovascular device company that is developing breakthrough solutions for mitral valve repair based on its proprietary helix technology. The company is based in Espoo, Finland. The company's lead products, CathHELIX® and MAR®, are transcatheter and surgical mitral valve repair devices that are designed to be faster, easier to use, and less invasive without compromising clinical efficacy. The company was founded by Olli Urho Tapani Keränen, and Tom Fleming has been the CEO of the company since 2022. | Medical Specialties | Director/Board Member | |
Innovestor Oy
![]() Innovestor Oy Investment ManagersFinance Innovestor Oy is a venture and growth equity firm headquartered in Helsinki, Finland. The firm was founded by Tommi Äijälä and Antti Parviainen in 2014. | Investment Managers | Private Equity Analyst | |
Sartar Therapeutics Oy | Director/Board Member | ||
Neurotar Oy | Director/Board Member | ||
BIORETEC OY | Medical Specialties | Director/Board Member | |
Aalto University | College/University | Graduate Degree | |
ACCENTURE PLC | Information Technology Services | Corporate Officer/Principal | |
VARIAN MEDICAL SYSTEMS, INC. | Medical Specialties | Corporate Officer/Principal | |
Lundbeck Ltd.
![]() Lundbeck Ltd. Pharmaceuticals: MajorHealth Technology Lundbeck Ltd. engages in the research, development, production, marketing and sale of pharmaceuticals. It provides services that aid in the treatment of CNS disorders, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy and insomnia. The company was founded in 1972 and is headquartered in St. Albans, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Heidelberg University (Ohio) | College/University | Undergraduate Degree | |
FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Director/Board Member | |
Institute for Molecular Medicine Finland
![]() Institute for Molecular Medicine Finland BiotechnologyHealth Technology The Institute for Molecular Medicine Finland engages in research, development, and training in molecular medicines. The private company is based in Helsinki, Finland. | Biotechnology | Corporate Officer/Principal | |
Cancer Research UK
![]() Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
BAUDAX BIO, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Master Golf Course Oy AB | Chairman | ||
TILT Biotherapeutics Oy
![]() TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology TILT Biotherapeutics Oy is a preclinical stage company working in the field of cancer immunotherapy. It develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment. The company was founded by Akseli Hemminki in 2013 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member | |
Medix Biochemica Oy Ab
![]() Medix Biochemica Oy Ab Medical SpecialtiesHealth Technology Medix Biochemica Oy Ab develops, produces, and markets monoclonal antibodies, antibody services, and recombinant antigens for in vitro diagnostics industry. It also provides rapid tests for human healthcare. The company was founded in 1985 and is headquartered in Espoo, Finland. | Medical Specialties | Director/Board Member | |
AIFORIA TECHNOLOGIES OYJ | Packaged Software | Chairman | |
Desentum Oy
![]() Desentum Oy BiotechnologyHealth Technology Desentum Oy operates as a research-based biopharmaceutical firm that specializes in developing novel types of allergen immunotherapy products that are based on switching the immune system's response to allergens. The company was founded by Janne Jänis, Marja-Leena Laukkanen, Pekka Allan Antero Mattila, Merja Niemi, Anja Pallas, Juha Rouvinen, and Kristiina Takkinen in 2011 and is headquartered in Espoo, Finland. | Biotechnology | Founder |
Statistik
International
Finnland | 35 |
Vereinigte Staaten | 9 |
Vereinigtes Königreich | 5 |
Estland | 2 |
Belgien | 2 |
Sektoral
Health Technology | 22 |
Consumer Services | 8 |
Commercial Services | 6 |
Technology Services | 6 |
Finance | 4 |
Operativ
Director/Board Member | 48 |
Corporate Officer/Principal | 21 |
Chairman | 15 |
Chief Executive Officer | 12 |
Founder | 8 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Sigrid Booms
- Unternehmensverbindungen